Key facts
- This page summarizes Rudolf Jaenisch's Form 3 filing for Omega Therapeutics, Inc. (OMGAQ).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 29 Jul 2021, 21:01.
Rudolf Jaenisch - 29 Jul 2021 Form 3 Insider Report for Omega Therapeutics, Inc. (OMGAQ)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- OMGAQ
- Reported as of
- 29 Jul 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Barbara Chan as Attorney-in-fact for Rudolf Jaenisch
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Rudolf Jaenisch filed Form 3 for Omega Therapeutics, Inc. (OMGAQ) on 29 Jul 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OMGA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 794,118
- Date
- 29 Jul 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Exhibit 24 - Power of Attorney.